Adjustment of drugs and nutrition in continuous renal replacement therapies

Six to 23% of patients with acute kidney injury (AKI) in intensive care units (ICU) require renal support. Continuous renal replacement therapies (CRRT) have become the modality of choice in critical care. Although the aim of CRRT is to restore the water and acid-base balance, together with the remo...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24111
Acceso en línea:
https://doi.org/10.24875/GMM.M18000065
https://repository.urosario.edu.co/handle/10336/24111
Palabra clave:
Acid base balance
Acute kidney failure
Antimicrobial activity
Antimicrobial therapy
Article
Continuous renal replacement therapy
Critically ill patient
Intensive care unit
Multiple organ failure
Nutrient
Nutritional support
Renal clearance
Renal replacement therapy
Sepsis
Acute kidney failure
Complication
Critical illness
Human
Intensive care
Intensive care unit
Procedures
Renal replacement therapy
Sepsis
Antiinfective agent
Acute kidney injury
Anti-infective agents
Critical care
Critical illness
Humans
Intensive care units
Nutritional support
Renal replacement therapy
Sepsis
Dose
Elimination
Extracorporeal
Hemofiltration
Nutrition
Therapeutical
Rights
License
Abierto (Texto Completo)
Description
Summary:Six to 23% of patients with acute kidney injury (AKI) in intensive care units (ICU) require renal support. Continuous renal replacement therapies (CRRT) have become the modality of choice in critical care. Although the aim of CRRT is to restore the water and acid-base balance, together with the removal of uremic and inflammatory toxins related to the loss of renal clearance and multi-organ dysfunction; we recognize as a side effect the unwanted clearance of molecules and substances desired for the recovery of the critically ill patient such as antimicrobials and nutrients. Sepsis is the most frequent cause of AKI in the ICU and, in this context, the appropriate selection of antimicrobial therapy, and at the correct dose, is one of the most important decisions; it is also essential to guarantee the adequate nutritional support in this population. We propose in this review a theoretical and practical approach to address the pharmacological management of antimicrobials and nutritional support in the patient in CRRT. © 2018, Academia Nacional de Medicina. All rights reserved.